Search results
Results from the WOW.Com Content Network
New York Jets (2009-14) Buffalo Bills (2015-16) Before his time with the Jets, Ryan worked on John Harbaugh's staff with the Baltimore Ravens for a decade. He began as a defensive line coach ...
The New York Jets interviewed former Washington and Carolina coach Ron Rivera on Thursday, the first known head coaching candidate to meet with the team. ESPN analyst and former NFL safety Louis ...
After playing his first seven years with the Ravens, Scott signed with the New York Jets in 2009. He would play his final four seasons for the Jets. [2] He was employed as an NFL analyst for CBS television from 2013 to 2017. Scott is currently employed as the co-host of Bart and Hahn weekdays 12 to 2 on ESPN Radio in New York City.
Mike Tannenbaum (born February 14, 1969) [1] is an American professional football analyst and former executive. He served as the executive vice president of football operations for the Miami Dolphins from 2015 to 2018.
On May 6, 2022, the New York Jets signed Charles to a three-year, $2.565 million contract as an undrafted free agent. [6] [7] On August 29, 2022, he was waived by the Jets. [6] [8] On August 31, 2022, the Jets signed Charles to their practice squad. [6] [8] On January 7, 2023, the Jets signed Charles to their active roster on a one-year ...
ESPN's latest "30 for 30" film takes an unvarnished look at the Jets' "New York Sack Exchange," from the dysfunctional group's rise to its fall.
The Jets' disappointing season closed on a high note, as Aaron Rodgers threw his 500th career touchdown pass to Tyler Conklin before adding three more in the game, while the Jets' defense forced four turnovers, defeating the Dolphins 32–20 and eliminating them from playoff contention.
Robert Wood Johnson IV (born April 12, 1947) is an American businessman who is co-owner of the New York Jets and was formerly the United States ambassador to the United Kingdom from 2017 to 2021. He is a great-grandson of Robert Wood Johnson I , and an heir to the Johnson & Johnson pharmaceutical fortune.